CD4 and neoplasm: M1-like macrophages infiltrating the tumor showed increased expression of major histocompatibility complex class II (MHCII) molecules (Fig. 5F), relevant for the presentation of tumor antigens to CD4+ T cells, after S3QEL 1.2 administration while M2-like macrophages presence showed a moderate decrease in the same group (Fig. 5G).